Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women.

被引:244
作者
Fung, TT [1 ]
Hu, FB
McCullough, ML
Newby, PK
Willett, WC
Holmes, MD
机构
[1] Simmons Coll, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[3] Amer Canc Soc, Atlanta, GA 30329 USA
[4] Tufts Univ, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA
关键词
breast cancer; diet; nutrition; estrogen receptor;
D O I
10.1093/jn/136.2.466
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Emerging evidence suggests that diet quality indices may serve as prognostic indicators of disease. However, the ability of these indices to predict breast cancer risk has not been evaluated previously. We assessed the association between several diet quality scores and the risk of breast cancer in postmenopausal women. The indices we used were the Healthy Eating Index (HEI), Alternate Healthy Eating Index (AHEI), Diet Quality Index-Revised (DQI-R), Recommended Food Score (RFS), and the alternate Mediterranean Diet Score (aMed). We calculated diet quality indices from dietary information collected in FFQ administered 5 times between 1984 and 1998 among women in the Nurses' Health Study cohort. Relative risks (RR) were computed using Cox proportional hazards models and adjusted for known risk factors for breast cancer. Separate analyses were conducted for estrogen receptor positive (ER+) and negative (ER-) tumors. Between 1984 and 2002, we documented 3580 cases of breast cancer, of which 2367 were ER+, and 575 were ER-. We did not observe any association between the diet quality indices and total or ER+ breast cancer risk. However, for ER- breast cancer, after adjusting for potential confounders, the FIR comparing highest to lowest quintiles were 0.78 (95% Cl = 0.59-1.04, P for trend = 0.01) for the AHEI, 0.69 (95% Cl = 0.51-0.94, P for trend = 0.003) for the RFS, and 0.79 (95% Cl = 0.60-1.03, P for trend = 0.03) for the aMed. These observations appeared to be the result of an inverse association (P for trend = 0.01) with the vegetable component of the scores. We conclude that women who scored high in AHEI, RFS, and aMed had a lower risk of ER- breast cancer. The HEI and DQI-R appeared to be of limited value in predicting breast cancer risk.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 50 条
[41]   NFIB is a potential target for estrogen receptor-negative breast cancers [J].
Moon, Hyeong-Gon ;
Hwang, Ki-Tae ;
Kim, Jeong-Ah ;
Kim, Hee Sung ;
Lee, Min-Joo ;
Jung, Eun-Mi ;
Ko, Eunyoung ;
Han, Wonshik ;
Noh, Dong-Young .
MOLECULAR ONCOLOGY, 2011, 5 (06) :538-544
[42]   Diet Quality Scores Inversely Associated with Postmenopausal Breast Cancer Risk Are Not Associated with Premenopausal Breast Cancer Risk in the California Teachers Study [J].
Haridass, Vikram ;
Ziogas, Argyrios ;
Neuhausen, Susan L. ;
Anton-Culver, Hoda ;
Odegaard, Andrew .
JOURNAL OF NUTRITION, 2018, 148 (11) :1830-1837
[43]   Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas [J].
Wei, Bing ;
Wang, Jianmin ;
Bourne, Patricia ;
Yang, Qi ;
Hicks, David ;
Bu, Hong ;
Tang, Ping .
HUMAN PATHOLOGY, 2008, 39 (12) :1809-1815
[44]   The Hedgehog Pathway Is a Possible Therapeutic Target for Patients with Estrogen Receptor-negative Breast Cancer [J].
Kameda, Chizu ;
Tanaka, Haruo ;
Yamasaki, Akio ;
Nakamura, Masafumi ;
Koga, Kenichiro ;
Sato, Norihiro ;
Kubo, Makoto ;
Kuroki, Syoji ;
Tanaka, Masao ;
Katano, Mitsuo .
ANTICANCER RESEARCH, 2009, 29 (03) :871-879
[45]   mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer [J].
Chao Cheng ;
Xuping Fu ;
Pedro Alves ;
Mark Gerstein .
Genome Biology, 10
[46]   Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II [J].
Hirko, Kelly A. ;
Fortner, Renee T. ;
Hankinson, Susan E. ;
Wu, Tianying ;
Eliassen, A. Heather .
BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) :149-155
[47]   Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses’ Health Study and Nurses’ Health Study II [J].
Kelly A. Hirko ;
Renée T. Fortner ;
Susan E. Hankinson ;
Tianying Wu ;
A. Heather Eliassen .
Breast Cancer Research and Treatment, 2016, 158 :149-155
[48]   Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers [J].
Fei, Fei ;
Siegal, Gene P. ;
Wei, Shi .
CLINICAL BREAST CANCER, 2022, 22 (07) :E788-E797
[49]   Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer [J].
Wang, Jun ;
Shidfar, Ali ;
Ivancic, David ;
Ranjan, Manish ;
Liu, Liannian ;
Choi, Mi-Ran ;
Parimi, Vamsi ;
Gursel, Demirkan B. ;
Sullivan, Megan E. ;
Najor, Matthew S. ;
Abukhdeir, Abde M. ;
Scholtens, Denise ;
Khan, Seema A. .
INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (11) :2484-2497
[50]   Eating Habits, Risk of Breast Cancer, and Diet-Dependent Quality of Life in Postmenopausal Women after Mastectomy [J].
Socha, Malgorzata ;
Sobiech, Krzysztof A. .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)